You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Rare Driver Gene

Showing 1 - 25 of 9,300
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Drive Decision-AIDS for Gene Therapy for Rare Diseases (GENETX)

Not yet recruiting
  • Sickle Cell Disease
  • Interview
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Mar 30, 2023

Resectable Stage II-IIIB Driver Gene-negative Non-small Cell

Not yet recruiting
  • NSCLC
    • Changsha, Hunan, China
      Hunan Cancer Hospital
    Aug 6, 2023

    Significance of MRD After Surgery in Driver Gene-positive and

    Enrolling by invitation
    • NSCLC MRD ctDNA
      • Shenzhen, China
        ShenzhenPH
      Jun 30, 2022

      Chinese Non-Small Cell Lung Cancer Rare Driver Gene Mutation

      Recruiting
      • Chinese
      • Non-Small Cell Lung Cancer
      • nonIntervention
      • Shanghai, Shanghai, China
        Shanghai Pulmonary Hospital
      Dec 24, 2019

      Lung Cancer Trial in Shanghai (chemo plus TCM 1&ICIs plusTCM2 , chemo plus TCM 1 &ICIs plus TCM2 )

      Not yet recruiting
      • Lung Cancer
      • chemotherapy plus TCM 1&ICIs plusTCM2 placebo
      • chemotherapy plus TCM 1placebo &ICIs plus TCM2 placebo
      • Shanghai, Shanghai, China
        YueYang Hosptial of Intergrated Traditional Chinese and Western
      Apr 17, 2023

      Atypical Hemolytic Uremic Syndrome Trial in Ranica (Blood sampling and urine analysis)

      Not yet recruiting
      • Atypical Hemolytic Uremic Syndrome
      • Blood sampling and urine analysis
      • Ranica, BG, Italy
        Centro di Ricerche Cliniche per le Malattie Rare "Aldo e Cele Da
      Mar 28, 2023

      Non Small Cell Lung Cancer, Endostatin Trial in Guangzhou (Endostatin)

      Not yet recruiting
      • Non Small Cell Lung Cancer
      • Endostatin
      • Guangzhou, Guangdong, China
        Affiliated Cancer Hospital and Institute of Guangzhou Medical Un
      Jul 4, 2022

      NSCLC, RET Driver Mutation, BRAF V600 Mutation Trial in Guanzhou (Toripalimab, Nab paclitaxel, Pemetrexed)

      Recruiting
      • Non-Small Cell Lung Cancer
      • +5 more
      • Toripalimab
      • +3 more
      • Guanzhou, Guangdong, China
        Guangdong Lung Cancer Institute, Guangdong Provincial People's H
      Apr 4, 2023

      Advanced Non-squamous Non-Small-Cell Lung Cancer Trial in Jinan (Sintilimab)

      Recruiting
      • Advanced Non-squamous Non-Small-Cell Lung Cancer
      • Jinan, Shandong, China
        The First Affiliated Hospital of Shandong First Medical Universi
      Dec 4, 2022

      Non-Small-Cell Lung Cancer Trial in Jinan (Recombinant human endostatin (Endostar))

      Recruiting
      • Non-Small-Cell Lung Cancer
      • Recombinant human endostatin (Endostar)
      • Jinan, Shandong, China
        The First Affiliated Hospital of Shandong First Medical Universi
      Oct 8, 2022

      NSCLC Trial in Changsha (Sintilimab Combined With Docetaxel Monotherapy)

      Completed
      • Non-small Cell Lung Cancer
      • Sintilimab Combined With Docetaxel Monotherapy
      • Changsha, Hunan, China
      • +1 more
      Mar 1, 2022

      NTRK Gene Fusion - Positive Advanced or Recurrent Solid

      Recruiting
      • Advanced or Recurrent Solid Tumor Harboring an NTRK Gene Fusion
      • Larotrectinib (Vitrakvi, BAY2757556)
      • Multiple Locations, Japan
        Many locations
      Jan 20, 2023

      NSCLC Metastatic Trial (bevacizumab plus nab-paclitaxel and platinum)

      Not yet recruiting
      • Non-small Cell Lung Cancer Metastatic
      • bevacizumab plus nab-paclitaxel and platinum
      • (no location specified)
      Jun 2, 2022

      Advanced Non Small Cell Lung Cancer Trial in Changsha (Toripalimab combination with platinum-containing dual-drug chemo)

      Recruiting
      • Advanced Non Small Cell Lung Cancer
      • Toripalimab combination with platinum-containing dual-drug chemotherapy
      • Changsha, Hunan, China
        Hunan Provincal Tumor Hospital
      Dec 28, 2021

      Study of Retinal Dystrophies Associated With Rare

      Active, not recruiting
      • Inherited Retinal Degeneration
      • Retinitis Pigmentosa
        • Phoenix, Arizona
        • +23 more
        Jan 24, 2023

        Driver Gene Abnormalities and Clinicopathological

        Recruiting
        • Lymphoma
        • Gene Abnormality
          • Zhengzhou, Henan, China
            Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZho
          Aug 15, 2021

          Pembrolizumab Combined With Double Platinum Based Chemotherapy

          Recruiting
          • Non Small Cell Lung Cancer
            • Changsha, Hunan, China
              Yongchang Zhang
            Feb 28, 2022

            Non Small Cell Lung Cancer Trial (Jinfukang oral liquid, Platinum-based doublet chemo)

            Not yet recruiting
            • Non Small Cell Lung Cancer
            • Jinfukang oral liquid
            • Platinum-based doublet chemotherapy
            • (no location specified)
            Oct 17, 2021

            PD-1 Antibody Plus Chemotherapy for TKI Failure Driver Gene

            Recruiting
            • Non Small Cell Lung Cancer
              • Changsha, Hunan, China
                Yongchang Zhang
              Mar 9, 2022

              Hyperferritinemia Candidate Gene

              Recruiting
              • Hyperferritinemia
              • Genetic analysis
              • Monza, MB, Italy
                Centre for Rare Disease - Disorders of Iron Metabolism, ASST-Mon
              Jan 17, 2023

              Duchenne Muscular Dystrophy Trial in United States (EDG-5506 Dose 1, EDG-5506 Dose 2, Placebo)

              Not yet recruiting
              • Duchenne Muscular Dystrophy
              • EDG-5506 Dose 1
              • +2 more
              • Los Angeles, California
              • +6 more
              Oct 26, 2023

              Gene Discovery Core, The Manton Center

              Recruiting
              • Undiagnosed Conditions
              • +2 more
                • Boston, Massachusetts
                  Boston Children's Hospital
                Aug 9, 2021

                Canavan Disease Trial in Boston (AAV9 BBP-812)

                Recruiting
                • Canavan Disease
                • AAV9 BBP-812
                • Boston, Massachusetts
                  Massachusetts General Hospital (MGH); Center for Rare Neurologic
                Mar 12, 2022

                Non-small Cell Lung Adenocarcinoma, Squamous Cell Carcinoma of Lung Trial in Guangzhou (SI-B001, Docetaxel)

                Not yet recruiting
                • Non-small Cell Lung Adenocarcinoma
                • Squamous Cell Carcinoma of Lung
                • Guangzhou, Guangdong, China
                  Sun Yat-sen University Cancer Center
                Jul 5, 2023

                NSCLC Trial in Shanghai (Camrelizumab, Famitinib)

                Not yet recruiting
                • NSCLC
                • Shanghai, Shanghai, China
                  Shanghai Chest Hospital
                Aug 5, 2021